Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Effects of the neuraminidase inhibitor zanamavir on otologic manifestations of experimental human influenza.

Walker JB, Hussey EK, Treanor JJ, Montalvo A Jr, Hayden FG.

J Infect Dis. 1997 Dec;176(6):1417-22.

PMID:
9395349
2.

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K.

N Engl J Med. 1997 Sep 25;337(13):874-80.

3.

Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.

Hedrick JA, Barzilai A, Behre U, Henderson FW, Hammond J, Reilly L, Keene O.

Pediatr Infect Dis J. 2000 May;19(5):410-7.

PMID:
10819336
4.

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.

Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU.

Antiviral Res. 1998 Feb;37(2):107-20.

PMID:
9588843
5.
6.

Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment.

Fritz RS, Hayden FG, Calfee DP, Cass LM, Peng AW, Alvord WG, Strober W, Straus SE.

J Infect Dis. 1999 Sep;180(3):586-93.

PMID:
10438343
7.

Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.

Calfee DP, Peng AW, Hussey EK, Lobo M, Hayden FG.

Antivir Ther. 1999;4(3):143-9.

PMID:
12731753
8.

Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis.

Monto AS, Webster A, Keene O.

J Antimicrob Chemother. 1999 Nov;44 Suppl B:23-9.

PMID:
10877459
9.

Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention.

Hayden FG.

Vaccine. 2000 Dec 8;19 Suppl 1:S66-70. Review.

PMID:
11163466
10.

Spotlight on zanamivir in influenza.

Cheer SM, Wagstaff AJ.

Am J Respir Med. 2002;1(2):147-52. Review.

PMID:
14720068
11.

Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.

Lalezari J, Campion K, Keene O, Silagy C.

Arch Intern Med. 2001 Jan 22;161(2):212-7.

PMID:
11176734
12.

Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.

Kaiser L, Henry D, Flack NP, Keene O, Hayden FG.

Clin Infect Dis. 2000 Mar;30(3):587-9.

PMID:
10722450
13.

Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.

Phillips TG.

J Fam Pract. 2003 Oct;52(10):747-8. No abstract available.

PMID:
14529590
14.

Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults.

Kaiser L, Keene ON, Hammond JM, Elliott M, Hayden FG.

Arch Intern Med. 2000 Nov 27;160(21):3234-40.

PMID:
11088083
15.

Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.

Monto AS, Pichichero ME, Blanckenberg SJ, Ruuskanen O, Cooper C, Fleming DM, Kerr C.

J Infect Dis. 2002 Dec 1;186(11):1582-8.

PMID:
12447733
16.

Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.

Matsumoto K, Ogawa N, Nerome K, Numazaki Y, Kawakami Y, Shirato K, Arakawa M, Kudoh S, Shimokata K, Nakajima S, Yamakido M, Kashiwagi S, Nagatake T.

Antivir Ther. 1999;4(2):61-8.

PMID:
10682150
17.

Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.

Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK.

JAMA. 1996 Jan 24-31;275(4):295-9.

PMID:
8544269
18.

The effect of zanamivir treatment on the early immune response to influenza vaccination.

Cox RJ, Mykkeltvedt E, Sjursen H, Haaheim LR.

Vaccine. 2001 Sep 14;19(32):4743-9.

PMID:
11535325
19.

Zanamivir: from drug design to the clinic.

Elliott M.

Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1885-93. Review.

20.

Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

Hayden FG, Gubareva LV, Monto AS, Klein TC, Elliot MJ, Hammond JM, Sharp SJ, Ossi MJ; Zanamivir Family Study Group..

N Engl J Med. 2000 Nov 2;343(18):1282-9.

Items per page

Supplemental Content

Support Center